In the context of breast cancer, the biological effect of CBD in the regulation of epithelial tumor pathophysiology has clearly emerged [18,19] and is thought to be due to multiple molecular targets including the CB1 and CB2 receptors. The gene discussed is CNR1; the disease is breast carcinoma.